Evidence map›Paper›PMID 40397242›Full record

ArticleInsights into imaging2025

Mammography-based artificial intelligence for breast cancer detection, diagnosis, and BI-RADS categorization using multi-view and multi-level convolutional neural networks.

Hongna Tan, Qingxia Wu, Yaping Wu, Bingjie Zheng, Bo Wang, Yan Chen, Lijuan Du, Jing Zhou, Fangfang Fu, Huihui Guo and 6 more

Abstract read
In one paragraph

Article in Insights into imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Hongna Tan *Department of Radiology, Henan Provincial People's Hospital & People's Hospital of Zhengzhou University, Zhengzhou, China.
Qingxia Wu *Beijing United Imaging Research Institute of Intelligent Imaging, Beijing, China.
Yaping Wu *Department of Radiology, Henan Provincial People's Hospital & People's Hospital of Zhengzhou University, Zhengzhou, China.
Bingjie ZhengDepartment of Radiology, Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University Zhengzhou, Henan, China.
Bo WangDepartment of Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yan ChenDepartment of Radiology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Lijuan DuDepartment of Radiology, Zhengzhou Central Hospital, Zhengzhou, China.
Jing ZhouDepartment of Radiology, Henan Provincial People's Hospital & People's Hospital of Zhengzhou University, Zhengzhou, China.
Fangfang FuDepartment of Radiology, Henan Provincial People's Hospital & People's Hospital of Zhengzhou University, Zhengzhou, China.
Huihui GuoDepartment of Radiology, Henan Provincial People's Hospital & People's Hospital of Zhengzhou University, Zhengzhou, China.
Cong FuDepartment of Radiology, Henan Provincial People's Hospital & People's Hospital of Zhengzhou University, Zhengzhou, China.
Lun MaDepartment of Radiology, Fuwai Central China Cardiovascular Hospital, Zhengzhou, China.
Pei DongBeijing United Imaging Research Institute of Intelligent Imaging, Beijing, China.
Zhong XueShanghai United Imaging Intelligence Co. Ltd, Shanghai, China.
Dinggang ShenShanghai United Imaging Intelligence Co. Ltd, Shanghai, China.
Meiyun WangDepartment of Radiology, Henan Provincial People's Hospital & People's Hospital of Zhengzhou University, Zhengzhou, China. mywang@zzu.edu.cn.ORCID http://orcid.org/0000-0002-7163-2617

Funding

Medical Science and Technological Project of Henan Province LHGJ20220055Medical Science and Technology Research Project of Henan Province SBGJ202101002National Science Foundation of China 81720108021Zhengzhou Collaborative Innovation Major Project 20XTZX05015
6 · The paper itself

Abstract

purposeWe developed an artificial intelligence system (AIS) using multi-view multi-level convolutional neural networks for breast cancer detection, diagnosis, and BI-RADS categorization support in mammography.

methodsTwenty-four thousand eight hundred sixty-six breasts from 12,433 Asian women between August 2012 and December 2018 were enrolled. The study consisted of three parts: (1) evaluation of AIS performance in malignancy diagnosis; (2) stratified analysis of BI-RADS 3-4 subgroups with AIS; and (3) reassessment of BI-RADS 0 breasts with AIS assistance. We further evaluate AIS by conducting a counterbalance-designed AI-assisted study, where ten radiologists read 1302 cases with/without AIS assistance. The area under the receiver operating characteristic curve (AUC), sensitivity, specificity, accuracy, and F1 score were measured.

resultsThe AIS yielded AUC values of 0.995, 0.933, and 0.947 for malignancy diagnosis in the validation set, testing set 1, and testing set 2, respectively. Within BI-RADS 3-4 subgroups with pathological results, AIS downgraded 83.1% of false-positives into benign groups, and upgraded 54.1% of false-negatives into malignant groups. AIS also successfully assisted radiologists in identifying 7 out of 43 malignancies initially diagnosed with BI-RADS 0, with a specificity of 96.7%. In the counterbalance-designed AI-assisted study, the average AUC across ten readers significantly improved with AIS assistance (p = 0.001).

conclusionAIS can accurately detect and diagnose breast cancer on mammography and further serve as a supportive tool for BI-RADS categorization. CRITICAL RELEVANCE STATEMENT: An AI risk assessment tool employing deep learning algorithms was developed and validated for enhancing breast cancer diagnosis from mammograms, to improve risk stratification accuracy, particularly in patients with dense breasts, and serve as a decision support aid for radiologists. KEY POINTS: The false positive and negative rates of mammography diagnosis remain high. The AIS can yield a high AUC for malignancy diagnosis. The AIS is important in stratifying BI-RADS categorization.

Indexed as

Artificial intelligenceBreast neoplasmsDeep learningDiagnosisMammography

Identifiers

PMID40397242
PMCPMC12095762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.